PeopleBio Statistics

Total Valuation

PeopleBio has a market cap or net worth of KRW 78.13 billion. The enterprise value is 79.70 billion.

Market Cap	78.13B
Enterprise Value	79.70B

Important Dates

The last earnings date was Thursday, November 14, 2024.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

PeopleBio has 21.03 million shares outstanding. The number of shares has increased by 33.80% in one year.

Current Share Class	n/a
Shares Outstanding	21.03M
Shares Change (YoY)	+33.80%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	10.55%
Owned by Institutions (%)	n/a
Float	17.57M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	16.60
PB Ratio	6.17
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-6.03
EV / Sales	17.87
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.04

Financial Position

The company has a current ratio of 2.39, with a Debt / Equity ratio of 0.13.

Current Ratio	2.39
Quick Ratio	0.89
Debt / Equity	0.13
Debt / EBITDA	n/a
Debt / FCF	-0.15
Interest Coverage	-13.42

Financial Efficiency

Return on equity (ROE) is -169.11% and return on invested capital (ROIC) is -51.77%.

Return on Equity (ROE)	-169.11%
Return on Assets (ROA)	-31.55%
Return on Capital (ROIC)	-51.77%
Revenue Per Employee	68.60M
Profits Per Employee	-203.21M
Employee Count	65
Asset Turnover	0.17
Inventory Turnover	1.28

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +7.45% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+7.45%
50-Day Moving Average	3,883.10
200-Day Moving Average	3,402.53
Relative Strength Index (RSI)	39.23
Average Volume (20 Days)	1,983,248

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PeopleBio had revenue of KRW 4.46 billion and -13.21 billion in losses. Loss per share was -663.03.

Revenue	4.46B
Gross Profit	1.42B
Operating Income	-13.08B
Pretax Income	-14.61B
Net Income	-13.21B
EBITDA	-11.42B
EBIT	-13.08B
Loss Per Share	-663.03

Full Income Statement

Balance Sheet

The company has 174.84 million in cash and 1.68 billion in debt, giving a net cash position of -1.50 billion or -71.41 per share.

Cash & Cash Equivalents	174.84M
Total Debt	1.68B
Net Cash	-1.50B
Net Cash Per Share	-71.41
Equity (Book Value)	12.73B
Book Value Per Share	602.23
Working Capital	5.71B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -10.86 billion and capital expenditures -450.80 million, giving a free cash flow of -11.31 billion.

Operating Cash Flow	-10.86B
Capital Expenditures	-450.80M
Free Cash Flow	-11.31B
FCF Per Share	-537.94

Full Cash Flow Statement

Margins

Gross margin is 31.92%, with operating and profit margins of -293.24% and -296.21%.

Gross Margin	31.92%
Operating Margin	-293.24%
Pretax Margin	-327.53%
Profit Margin	-296.21%
EBITDA Margin	-256.15%
EBIT Margin	-293.24%
FCF Margin	-253.72%

Dividends & Yields

PeopleBio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-33.80%
Shareholder Yield	-33.80%
Earnings Yield	-17.85%
FCF Yield	-14.48%

Stock Splits

The last stock split was on October 23, 2023. It was a forward split with a ratio of 1.2.

Last Split Date	Oct 23, 2023
Split Type	Forward
Split Ratio	1.2

Scores

PeopleBio has an Altman Z-Score of -1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1
Piotroski F-Score	n/a